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Medeiros WM, Fernandes MC, Azevedo DP, de Freitas FF,
Amorim BC, Chiavegato LD, Hirai DM, O’Donnell DE, Neder
JA. Oxygen delivery-utilization mismatch in contracting locomotor
muscle in COPD: peripheral factors. Am J Physiol Regul Integr Comp
Physiol 308: R105–R111, 2015. First published December 4, 2014;
doi:10.1152/ajpregu.00404.2014.—Central cardiorespiratory and gas
exchange limitations imposed by chronic obstructive pulmonary dis-
ease (COPD) impair ambulatory skeletal muscle oxygenation during
whole body exercise. This investigation tested the hypothesis that
peripheral factors per se contribute to impaired contracting lower limb
muscle oxygenation in COPD patients. Submaximal neuromuscular
electrical stimulation (NMES; 30, 40, and 50 mA at 50 Hz) of the
quadriceps femoris was employed to evaluate contracting skeletal
muscle oxygenation while minimizing the influence of COPD-related
central cardiorespiratory constraints. Fractional O2 extraction was
estimated by near-infrared spectroscopy (deoxyhemoglobin/myoglo-
bin concentration; deoxy-[Hb/Mb]), and torque output was measured
by isokinetic dynamometry in 15 nonhypoxemic patients with mod-
erate-to-severe COPD (SpO2  94  2%; FEV1  46.4  10.1%;
GOLD II and III) and in 10 age- and gender-matched sedentary
controls. COPD patients had lower leg muscle mass than controls
(LMM  8.0  0.7 kg vs. 8.9  1.0 kg, respectively; P  0.05) and
produced relatively lower absolute and LMM-normalized torque
across the range of NMES intensities (P  0.05 for all). Despite
producing less torque, COPD patients had similar deoxy-[Hb/Mb]
amplitudes at 30 and 40 mA (P  0.05 for both) and higher
deoxy-[Hb/Mb] amplitude at 50 mA (P  0.05). Further analysis
indicated that COPD patients required greater fractional O2 extraction
to produce torque (i.e., 1deoxy-[Hb/Mb]/torque) relative to con-
trols (P  0.05 for 40 and 50 mA) and as a function of NMES
intensity (P  0.05 for all). The present data obtained during sub-
maximal NMES of small muscle mass indicate that peripheral abnor-
malities contribute mechanistically to impaired contracting skeletal
muscle oxygenation in nonhypoxemic, moderate-to-severe COPD
patients.
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REDUCED PHYSICAL CAPACITY is a hallmark of patients suffering
from chronic obstructive pulmonary disease (COPD; Refs. 20,
37). A complex interplay of central and peripheral mechanisms
has been ascribed to contribute to the early onset of fatigue in
these patients (1, 14, 38). Notwithstanding inherent cardiore-
spiratory abnormalities, mounting evidence suggests a role for
skeletal muscle dysfunction in limiting exercise in COPD (20).
Mechanical efficiency, defined as the chemical conversion
of energy to external mechanical work, has been reported
previously to be reduced in COPD (2, 43). Recent evaluations
of skeletal muscle energetics using 31P-magnetic resonance
spectroscopy (31P-MRS) revealed that, despite the presence of
preserved mitochondrial function, patients with COPD exhibit
greater ATP cost of muscle contraction compared with age-
and physical activity-matched healthy counterparts (29, 30).
This implies that a given absolute work rate would require
greater energy supply to match the metabolic demand of
skeletal muscles of COPD patients. Furthermore, it is impor-
tant to note that COPD is associated with peripheral vascular
dysfunction, a condition that likely impairs contracting muscle
blood flow and thus O2 delivery (6, 12, 17, 27). However, it
remains unclear whether peripheral skeletal muscle dysfunc-
tion per se plays a mechanistic role in the mismatch between
O2 delivery and utilization (Q˙ O2 and V˙ O2, respectively) during
transitions in metabolic demand in COPD. As dictated by
Fick’s law of diffusion, a Q˙ O2/V˙ O2 imbalance lowers the
driving force for blood-myocyte O2 transfer (microvascular
partial pressure of O2; PO2mv) and contributes significantly to
impaired oxidative metabolism and contractile performance
(25, 47, 53). Resolution of this issue is therefore essential to
understanding muscle metabolic control and (poor) exercise
capacity in COPD and facilitate the development of novel and
effective therapeutic strategies.
It is essential to acknowledge that previous studies utilizing
high-intensity whole body exercise (such as supra-gas ex-
change threshold cycling exercise; Ref. 11) have not been
designed to examine the potential contribution of peripheral
dysfunction to contracting skeletal muscle Q˙ O2/V˙ O2 mismatch
in COPD. Such experimental protocols employ exercise mo-
dalities that recruit a large muscle mass and, consequently, are
constrained by central cardiorespiratory limitations imposed by
COPD (e.g., dynamic hyperinflation, expiratory flow limita-
tion, and augmented respiratory muscle recruitment). Consis-
tent with this notion, interventions aimed at ameliorating these
central limitations in COPD (via heliox, pharmacological bron-
chodilators, and respiratory muscle unloading; Refs. 8, 10, 11,
see also Refs. 32, 44) are capable of improving skeletal muscle
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Q˙ O2/V˙ O2 balance during high-intensity cycling exercise. These
studies provide a mechanistic link between central, but not
peripheral, limitations characteristic of COPD and contracting
skeletal muscle Q˙ O2/V˙ O2 mismatch. However, because of the
multifactorial nature of exercise intolerance in COPD, a dif-
ferent experimental approach is required to explore the poten-
tial contribution of peripheral factors in determining skeletal
muscle Q˙ O2/V˙ O2 mismatch during submaximal contractions in
vivo.
Electrically evoked contractions allow the investigation of
skeletal muscle function while minimizing the influence of
COPD-related central cardiorespiratory constraints and poten-
tial motivational bias (36, 51). Therefore, the purpose of the
current investigation was to examine the dynamic (mis)match-
ing between skeletal muscle Q˙ O2 and V˙ O2 (noninvasive fre-
quency-modulated near-infrared spectroscopy; NIRS) across a
range of submaximal contractions elicited via neuromuscular
electrical stimulation (NMES) in nonhypoxemic, stable mod-
erate-to-severe COPD patients. It was hypothesized that, com-
pared with age- and gender-matched sedentary controls, COPD
patients would manifest marked Q˙ O2/V˙ O2 mismatch and, there-
fore, greater changes in skeletal muscle deoxygenation (i.e.,
NIRS-derived deoxyhemoglobin/myoglobin concentration; de-
oxy-[Hb/Mb], an index of fractional O2 extraction) during
submaximal electrically evoked contractions. Empirical vali-
dation of this hypothesis would provide novel evidence that
peripheral abnormalities per se contribute to contracting mus-
cle oxygenation deficits in COPD patients.
METHODS
Fifteen males (aged 60 yr, body mass index 30 kg/m2) with
COPD according to the GOLD criteria (GOLD; Ref. 20) were referred
from the outpatient clinic of the São Paulo Hospital (Federal Univer-
sity of São Paulo, Brazil) for study participation. Patients were not
entitled to long-term or exertional O2 supplementation and presented
with moderate-to-severe airway obstruction;i.e., forced expiratory
volume in 1 s (FEV1)/forced vital capacity (FVC)0.7 and postbron-
chodilator FEV1 between 30% and 80% predicted (GOLD spirometric
stages II and III). No patient had been previously enrolled in a
pulmonary rehabilitation program. All patients were clinically stable
as indicated by no change in medical therapy (including oral cortico-
steroid use) or exacerbation of symptoms within the preceding 12 wk.
Current COPD treatment included short- and long-acting bronchodi-
lators combined with ot without inhaled corticosteroids. Main exclu-
sion criteria were the following: locomotor or neurological deficits,
malignancy; cardiac failure; insulin-dependent diabetes mellitus; dis-
tal arteriopathy; 1-antiprotease deficiency; recent surgery; endocrine,
hepatic, or renal disorder; and anticoagulant or oral corticosteroid use.
Ten age-matched, nonsmoking males with no cardiovascular, respi-
ratory, or metabolic diseases served as controls. Healthy nonsmoking
participants had not undertaken any regular physical activity in the
preceding year. The Research Ethics Committee of Federal University
of São Paulo approved the study and informed consent was obtained
from all participants.
Regular physical activity. The Baecke’s Questionnaire was admin-
istered to obtain an index of regular physical activity (3). The
questionnaire includes 16 questions involving three domains: 1)
occupational physical activity (8 questions); 2) physical exercise in
leisure time (4 questions); and 3) leisure and locomotion-related
physical activities (4 questions). The total score is the arithmetic mean
of the domain scores.
Leg muscle mass. Dominant leg muscle mass was measured (from
the gluteal furrow to the minimum circumference above the ankle)
using dual energy X-ray absorptiometry (DEXA; Lunar DPX IQ,
Lunar Radiation; Madison, WI). Leg muscle mass (LMM; expressed
in kg) was then obtained as the limb mass minus the sum of fat and
bone mass.
Spirometry. Spirometric tests were performed using the CPF sys-
tem (Medical Graphics; St. Paul, MN) with airflow being measured by
a calibrated pneumotachograph. Patients completed at least three
acceptable maximal forced expiratory maneuvers before and after
400 g of inhaled salbutamol; in the present communication, only
postbronchodilator data are reported. FVC and FEV1 were recorded
and expressed as percentage of the predicted value.
Knee extensor muscle torque evaluation. Isometric knee extension
torque development of the dominant leg was assessed using an
isokinetic dynamometer (Con-Trex, CH 8046; Zurich, Switzerland)
both in response to maximal voluntary and electrically evoked con-
tractions. Positioning and stabilization of each subject were standard-
ized. The mechanical axis of rotation of the lever arm was aligned to
the axis of rotation of the knee. The resistance pad at the end of the
lever arm was strapped to the distal part of tibia; the exact position
varied according to the subject’s leg length. Correction for the effect
of gravity on neuromuscular performance was made by incorporating
limb mass to the calculation of torque production. This was done
before experimental procedures by fixing the dominant leg to the lever
arm positioned at 100° for 5 s while muscles remained relaxed and the
limb rested on support. Subsequently, subjects performed two maxi-
mal isometric tests separated by a 5-min resting period. During the
voluntary isometric tests, subjects were asked to sustain the lever arm
at 100° for 5 s while the force applied was recorded instantaneously
(peak torque expressed in Nm). For the electrically evoked contrac-
tions, subjects were specifically told to avoid any concomitant volun-
tary muscle activation.
Electrical stimulation protocol. Knee extensor muscles (quadriceps
femoris) of the dominant leg were electrically stimulated (Dualpex
961, Quark; Brazil) with the subjects seated comfortably on the
isokinetic dynamometer and with the near-infrared spectroscopy
(NIRS) electrodes placed on the thigh (see Near-infrared spectros-
copy). Four NMES electrodes were placed on the: 1) middle third and
2) proximal portion of the vastus lateralis belly, 3) middle third of the
vastus medialis, and 4) proximal portion of the rectus femoris.
Electrode placement varied slightly among subjects to evoke maxi-
mum visible contractions. A 400-s wide, pulsed, biphasic, and
symmetric rectangular current at 50 Hz was used. Stimulations were
applied three times at each progressively higher intensity (order: 3 	
30, 3 	 40, and 3 	 50 mA) with an “on-off” cycle of 20:120 s. Each
set was separated by a 5-min resting period. A priori analysis revealed
no significant differences among the variables of interest among the
three consecutive contractions at a given NMES intensity (P  0.05).
The present communication thus presents the responses observed
during the first contraction of each NMES intensity.
Near-infrared spectroscopy. A frequency-domain multidistance
NIRS system (OxiplexTS, ISS; Champaign, IL) was used to evaluate
skeletal muscle oxygenation. Principles of operation and algorithms
have been described in detail elsewhere (21). This system provides
real-time, absolute (M) values of the chromophores of interest, i.e.,
oxygenated and deoxygenated hemoglobin/myoglobin (oxy-[Hb/Mb]
and deoxy-[Hb/Mb]; respectively), as well as total hemoglobin/myo-
globin (total-[Hb/Mb]). As described in detail by our group (11) and
others (e.g., 5, 18, 23, 28), deoxy-[Hb/Mb] was selected as the
preferential index of muscle deoxygenation during contractions be-
cause this signal is relatively insensitive to blood volume changes and
interpreted, therefore, as a proxy for muscle fractional O2 extraction.
In the present study, we used a single channel consisting of eight
laser diodes operating at two wavelengths (690 and 830 nm, four at
each wavelength) and a photomultiplier tube. The frequency was
modulated at 110 MHz. The laser diodes and photomultiplier tube are
connected to a lightweight plastic probe by optical fibers consisting of
two parallel rows of emitter fibers and one detector fiber bundle
comprising source-detector separations of 2.0, 2.5, 3.0, and 3.5 cm for
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both wavelengths. The probe was positioned longitudinally on the
middle third of the vastus lateralis muscle (
15–20 cm above the
patella) immediately below the NMES electrode 1. To minimize
motion artifacts and contamination of the signal by ambient light after
careful shaving and drying of the area, the probe was secured with
Velcro straps around the thigh. The near-infrared spectrometer was
calibrated on each test day after a warm-up period of at least 30 min.
The calibration was performed by placing the optical probe on a
calibration block (phantom) with known absorption and reduced
scattering coefficients. Correction factors were determined and imple-
mented automatically by the equipment’s software for the calculation
of the absorption coefficient (A) and reduced scattering coefficient
(s=) for each wavelength (26), i.e., no constant value for photon
scattering was assumed herein.
Statistical analyses. Means  SD were the measures of central
tendency and dispersion. Between-group differences were assessed by
unpaired Student’s t-tests. Comparisons across intensity of NMES
were performed using mixed-effects analysis of variance (generalized
linear mixed model) considering intra- and intersubject random ef-
fects. The probability of a type I error was established at 0.05 for all
tests.
RESULTS
Participant characteristics. As shown in Table 1, COPD
patients presented with significantly lower LMM than controls
despite similar body mass index. As expected by the inclusion
criteria, all patients had resting SpO2  92%. Although phys-
ical activity scores were slightly lower in COPD compared
with that achieved by controls (P  0.05), these scores char-
acterize both groups as sedentary (3; see DISCUSSION).
Torque production. Patients with COPD produced lower
absolute torque across the entire range of NMES intensities
compared with controls (Fig. 1, P  0.05 for all). Similar
results were found when adjusting torque for LMM by DEXA
(data not shown). Results are thus presented herein as absolute
torque (Nm). As expected, torque production increased as a
function of NMES intensity in both groups (Fig. 1; P  0.05
for all).
When expressed as a percentage of MVC, torque production
also increased with NMES intensity in both COPD (30 mA 
10.7  6.4, 40 mA  18.1  9.0, 50 mA  22.4  8.5%
MVC) and control (30 mA 11.7 7.0, 40 mA 20.2 7.3,
50 mA  27.1  8.3% MVC; P  0.05 for all). However,
between-group differences in torque (% MVC) were observed
only at 50 mA (P  0.05).
Skeletal muscle oxygenation. Representative deoxy-[Hb/
Mb] responses during submaximal NMES stimulation of the
quadriceps femoris of COPD patients and control subjects are
depicted in Fig. 2.
Table 1. General characteristics of COPD patients and
controls
COPD (n  15) Control (n  10) P
Age, yr 65.2 6.1 65.2  4.1 0.50
Height, cm 166.7 5.2 170.1  7.7 0.12
Body mass, kg 72.3 10.1 74.8  12.5 0.30
Body mass index, kg/m2 26.0  2.9 26.1  4.4 0.93
Leg mass, kg 10.8  1.1 11.9  2.0 0.15
Leg muscle mass, kg 8.0  0.7 8.9  1.0 0.02
Leg muscle mass/leg mass, % 74.0  3.5 75.7  7.3 0.51
Leg fat mass, kg 2.8  0.6 2.9  1.3 0.73
Leg bone mass, kg 0.49  0.1 0.55  0.1 0.07
FEV1/FVC 43.2  8.8
FEV1, liter 1.3  0.3
FEV1, % 46.4  10.1
FVC, % 79.7 10.5
SpO2, % 94  2 96  1 0.01
Peak torque, Nm 121.5 28.4 152.0  21.2 0.01
Physical activity score 7.0 1.0 7.9  1.0 0.02
Values are means  SD; n, number of subjects. COPD, chronic obstructive
pulmonary disease; FEV1, postbronchodilator forced expiratory volume in 1 s;
FVC, forced vital capacity; SpO2, oxygen saturation by pulse oximetry.
Fig. 1. Skeletal muscle (quadriceps femoris) torque production in COPD
patients and control subjects during submaximal NMES. P 0.05: *intragroup
difference vs. the previous value; †intergroup differences at a given NMES
intensity.
Fig. 2. Changes in skeletal muscle (quadriceps femoris) deoxy-hemoglobin/
myoglobin concentration (deoxy-[Hb/Mb]) in a representative COPD patient
(top) and control subject (bottom) during submaximal NMES.
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No differences in resting deoxy-[Hb/Mb] were found be-
tween COPD (30 mA  11.6  2.2, 40 mA  11.5  2.3, 50
mA  11.6  2.3 M) and control (30 mA  10.0  1.4, 40
mA 10.1 1.5, 50 mA 10.3 1.4 M; P 0.05 for all).
Similarly, there were no differences in resting deoxy-[Hb/Mb]
among NMES intensities within groups (P  0.05 for all).
Despite producing less torque, COPD patients had similar
deoxy-[Hb/Mb] amplitudes at 30 and 40 mA (P  0.05 for
both) and higher deoxy-[Hb/Mb] amplitude at 50 mA (P 
0.05) compared with control (Fig. 3). As expected, deoxy-[Hb/
Mb] amplitudes increased as a function of NMES intensity in
both groups (Fig. 3; P  0.05 for all).
Consistent with altered torque and deoxy-[Hb/Mb] re-
sponses during NMES in COPD, patients displayed greater
changes in deoxy-[Hb/Mb] per unit of torque output (i.e.,
1deoxy-[Hb/Mb]/torque) across the range of NMES inten-
sities compared with controls (Fig. 4; P  0.05 for 40 and 50
mA). Different from controls, deoxy-[Hb/Mb]/torque in
COPD was progressively greater as a function of NMES
intensity (Fig. 4; P  0.05 for all).
DISCUSSION
The present investigation demonstrates, for the first time,
that nonhypoxemic moderate-to-severe COPD patients display
altered torque production and ambulatory muscle deoxygen-
ation across a range of submaximal NMES compared with age-
and gender-matched sedentary controls. Specifically, patients
produced lower torque values in association with impaired
muscle oxygenation (i.e., greater changes in deoxy-[Hb/Mb])
during NMES relative to controls. This resulted in greater
muscle fractional O2 extraction per torque output (i.e.,
1deoxy-[Hb/Mb]/torque) in COPD than control. These re-
sults support the hypothesis that local peripheral abnormalities
contribute mechanistically to impaired contracting skeletal
muscle oxygenation in COPD patients.
Comparison with previous research. As mentioned above,
the previous finding of relatively faster dynamics and greater
amplitude of deoxy-[Hb/Mb] change during heavy-intensity
cycling exercise in patients with COPD (11) does not provide
direct evidence that peripheral disturbances per se might affect
negatively skeletal muscle Q˙ O2/V˙ O2 matching. In fact, Chiappa
et al. (11) demonstrated that impaired contracting muscle
oxygenation in COPD is associated with blunted central he-
modynamic responses (slower kinetics of cardiac output) in
those experimental conditions. Moreover, subsequent studies
aiming at ameliorating central cardiorespiratory constraints
imposed by COPD (via heliox, pharmacological bronchodila-
tors, and respiratory muscle unloading; Refs. 8, 10, 11, see also
Refs. 32, 44) improved peripheral deoxy-[Hb/Mb] during cy-
cling exercise and provided a mechanistic link between central
impairments and contracting skeletal muscle Q˙ O2/V˙ O2 mis-
match.
The current investigation employed small muscle mass
NMES to assess potential peripheral limitations associated
with muscle Q˙ O2/V˙ O2 mismatch in COPD patients, based on
the fact that this experimental paradigm minimizes consider-
ably the influence of central respiratory and cardiovascular
restraints on lower limb skeletal muscle function (36, 51). In
addition, NMES allowed quantification of muscle torque pro-
duction for a given stimulation intensity and revealed that
patients required relatively greater fractional O2 extraction per
unit of torque output (i.e., 1deoxy-[Hb/Mb]/torque; Fig. 4).
These abnormalities were aggravated by the intensity of met-
abolic activation given the progressively greater fractional O2
extraction per unit of torque production as a function of NMES
intensity in COPD (Fig. 4). These results extend those reported
previously during high-intensity whole body exercise (8, 10,
11, 46) by demonstrating the participation of peripheral factors
in contracting skeletal muscle Q˙ O2/V˙ O2 mismatch in COPD.
The implications of muscle Q˙ O2/V˙ O2 imbalance include a
reduced O2 extraction reserve that mandates an exaggerated
fall in intramyocyte PO2 and perturbation of the intracellular
environment (e.g.,1[ADP],2[PCr]; Refs. 25, 47, 53). These
are anticipated to enhance glycolysis and utilization of finite
energy sources and contribute to the early onset of leg fatigue
in COPD.
Potential peripheral mechanisms of impaired contracting
muscle oxygenation in COPD. The NIRS-derived deoxy-[Hb/
Mb] signal provides a noninvasive index of muscle microvas-
cular (de)oxygenation (or fractional O2 extraction) that is
Fig. 4. Mean changes in skeletal muscle (quadriceps femoris) deoxy-hemo-
globin/myoglobin concentration per unit of torque output (deoxy-[Hb/Mb]/
torque) in COPD patients and control subjects during submaximal NMES.
Note that COPD patients demonstrated higher deoxy-[Hb/Mb]/torque values
(i.e., increased fractional O2 extraction to produce torque) relative to control
subjects and as a function of NMES intensity. P 0.05: *intragroup difference
vs. the previous value; †intergroup differences at a given NMES intensity.
Fig. 3. Mean changes in skeletal muscle (quadriceps femoris) deoxy-hemo-
globin/myoglobin concentration (deoxy-[Hb/Mb]) in COPD patients and
control subjects during submaximal NMES. P  0.05: *intragroup difference
vs. the previous value; †intergroup differences at a given NMES intensity.
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reflective of the dynamic Q˙ O2/V˙ O2 matching during transitions
in metabolic demand (18, 28). Relatively greater deoxy-[Hb/
Mb] change during NMES in COPD patients (Figs. 2 and 3)
thus suggest an impaired adjustment of muscle Q˙ O2 relative to
V˙ O2 (19). As noted above, this response likely stems from
increased ATP cost of contractions (and thus O2 cost; Refs. 29,
30, 43) and/or peripheral vascular dysfunction (expected to
reduce contracting muscle blood flow and thus O2 delivery;
Refs. 6, 17, 27) in COPD.
As reviewed by Wagner (52), a number of potential mech-
anisms typically invoked to explain skeletal muscle dysfunc-
tion in COPD patients could be dismissed due to long-term
physical inactivity. On the other hand, the substantial increase
in the proportion of type II (fast twitch, glycolytic) muscle
fibers in the lower limb of COPD patients relative to physical
activity-matched controls (43) could contribute to reduced
mechanical efficiency as reported previously (2, 29, 30, 43).
Shifts in muscle fiber types in the lower limb muscles of COPD
may be regulated by several distinct signaling pathways, in-
cluding mitogen-activated protein kinase (16, 31). The mech-
anisms associated with increased cost of developing tension in
COPD might derive from differences in myosin ATPase ac-
tivity and cost of calcium handling between fast- and slow-
twitch fiber types (24, 48). In this context, a proportionally
greater activation of type II fibers in COPD would be associ-
ated with increased ATP cost of contractions (and thus O2 cost;
Refs. 29, 30, 43) and thereby muscle fractional O2 extraction
(present results; Figs. 2 and 3). This is consistent with reports
of greater fractional O2 extraction (i.e., 2PO2mv assessed via
phosphorescence quenching) during submaximal electrically
induced twitch contractions in fast- compared with slow-twitch
muscles of the healthy rat hindlimb (35).
Impaired contracting muscle oxygenation in COPD could
also originate from blunted muscle hyperemia secondary to
peripheral vascular dysfunction (6, 17, 27). Putative mecha-
nisms accounting for COPD-related vascular dysfunction in-
clude marked sympathetic activation (12), altered redox bal-
ance (i.e., oxidative stress; Refs. 27, 34), and vascular inflam-
mation (17). Although the exact factors underlying excessive
reactive oxygen species within skeletal muscle in COPD are
not entirely clear (42), fiber type shifting could also play a
considerable role in this respect given that type II fibers are
characterized by greater production and lower scavenging of
reactive oxygen species compared with type I fibers (40). In
addition, the possibility exists that chronic lung inflammation
characteristic of COPD evokes systemic responses that culmi-
nate in both peripheral oxidative stress and vascular inflam-
mation (22). One prominent common pathophysiological con-
sequence is impaired endothelium-dependent vasodilation con-
sequent to reduced nitric oxide bioavailability (7, 50). Of note,
others have assessed directly skeletal muscle conduit blood
flow of COPD patients and reported either preserved or in-
creased values across a range of submaximal work rates (33,
43, 45). Nevertheless, it is important to consider that conduit
artery blood flow responses may not necessarily reflect those of
the muscle microvasculature (which constitutes the primary
locus of O2 exchange and the site of NIRS interrogation)
during submaximal contractions (23).
The ability to assess torque generation via NMES indepen-
dently of volitional activation herein circumvented potential
motivational bias and evidenced lower torque in COPD pa-
tients compared with control (Fig. 1). Although not unequiv-
ocal (15, 54), a rightward shift of the force-frequency relation-
ship reported previously in COPD patients (13) would require
a higher stimulation intensity to produce the same absolute
force and account for, at least in part, the reduced torque output
observed presently. This behavior could be related to decreased
calcium sensitivity of submaximal force generation reported
previously in both slow- and fast-twitch isolated fibers from the
diaphragm of COPD patients (39, 49). Importantly, the current
findings at the level of the microcirculation of increased muscle
fractional O2 extraction per unit of torque (Fig. 4) bridge the
gap between reports of lower mechanical efficiency observed
at the mouth (1pulmonary V˙ O2/work rate; Ref. 2) and muscle
(1muscle V˙ O2/work rate using thermodilution; Ref. 43;
1ATP cost of contraction using 31P-MRS; Refs. 29, 30)
during transitions in metabolic demand in COPD.
Clinical implications. Similar to what has been postulated
previously for the respiratory muscles (1), the current data
suggest that Q˙ O2/V˙ O2 mismatch (1deoxy-[Hb/Mb]; Figs. 2
and 3) in the ambulatory muscles may also contribute to
reduced exercise capacity in COPD (although primarily during
activities that do not engage large muscle mass and require
large adjustments in central cardiorespiratory responses; Ref.
44). Thus patients may not only benefit from interventions that
ameliorate primarily central function (8, 10, 11), but also from
those improving directly lower limb skeletal muscle function.
Of note, dietary nitrate supplementation constitutes a potential
candidate given its ability to reduce both skeletal muscle
fractional O2 extraction and ATP cost of contractions in
healthy young subjects (4, 5).
NMES has been used as a rehabilitative tool in patients with
COPD with relative success in improving lower limb muscle
function via multiple mechanisms (36, 51). Nevertheless, in
healthy young subjects, chronic NMES has been found re-
cently to produce no improvement in contracting muscle oxy-
genation despite increasing maximal isometric force (41).
Whether similar adaptations (or lack thereof) in Q˙ O2/V˙ O2
control occur in the lower limb muscle of COPD patients
following NMES training remains to be determined.
Experimental considerations. The present investigation is
based on a modest sample size (n  15) of nonhypoxemic
moderate-to-severe COPD patients and thus may not be rep-
resentative of the entire COPD population. In this context, it is
plausible that hypoxemic and/or more severe COPD patients
may demonstrate even greater impairments in locomotor intra-
muscular function.
Although the small but significant difference in physical
activity between our patients and controls needs to be acknowl-
edged (Table 1), it is important to note that the low scores
observed herein categorize both groups as sedentary (3). More-
over, reduced mechanical efficiency (as evidenced by in-
creased ATP, and thus, O2 cost of muscle contractions) in
COPD patients is unlikely to derive from contrasting fitness
levels alone (29, 30, 43). Thus it is reasonable to consider that
impaired skeletal muscle oxygenation in COPD patients during
submaximal NMES is, at least to some extent, related to
peripheral (intramuscular) abnormalities.
The technical aspects and inherent limitations of NIRS-
based technology have been discussed at length elsewhere
(e.g., 5, 10, 11, 18, 23, 28, 46). A strength of the current
investigation is the utilization of frequency-modulated NIRS,
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which has the singular advantage over traditional spatially
resolved NIRS systems as it provides continuous measurement
of the absolute, as opposed to the relative change in, deoxy-
[Hb/Mb].
The present NMES experimental protocol differs from vol-
untary dynamic exercise in many aspects, including the evoked
skeletal muscle recruitment pattern. Although not following
strictly the size principle of voluntary motor unit recruitment,
NMES induces a nonspecific pattern of activation where both
slow- and fast-twitch fibers are recruited at low and high
intensities (9). This actually represents one of the main clinical
advantages of NMES given that virtually all muscle fiber types
have the potential to be recruited regardless of the intensity of
the protocol. Moreover, this behavior is particularly relevant to
those patients with acute exacerbation of COPD who might,
arguably, benefit the most from a rehabilitative strategy that
imposes essentially no central respiratory or cardiovascular
burden (36, 51).
Although strong evidence supports the significant 1) in-
crease in the proportion of type II muscle fibers in the lower
limb of COPD patients relative to physical activity-matched
controls (43), 2) peripheral oxidative stress (27, 34), and 3)
vascular inflammation (17), blood and muscle samples were
not taken herein and thus speculations were made regarding
their potential contribution to impaired muscle oxygenation in
COPD. Nonetheless, to the best of our knowledge, this is the
first study to indicate the participation of peripheral factors per
se on ambulatory muscle Q˙ O2/V˙ O2 mismatch in COPD patients.
Future studies designed to elucidate the mechanisms responsi-
ble for these derangements will be valuable.
Perspectives and Significance
Nonhypoxemic patients with moderate-to-severe COPD
produced lower torque together with greater muscle deoxygen-
ation during submaximal NMES relative to sedentary controls.
As a result, COPD patients required greater fractional O2
extraction to produce a given torque compared with controls, a
behavior that was aggravated as a function of NMES intensity.
The present data obtained during submaximal, electrically
evoked contractions of small muscle mass suggest that periph-
eral abnormalities contribute mechanistically to impaired skel-
etal muscle oxygenation during metabolic transitions in non-
hypoxemic, moderate-to-severe COPD patients.
REFERENCES
1. Aliverti A, Macklem PT. The major limitation to exercise performance in
COPD is inadequate energy supply to the respiratory and locomotor
muscles. J Appl Physiol (1985) 105: 749–751, 2008.
2. Baarends EM, Schols AM, Akkermans MA, Wouters EF. Decreased
mechanical efficiency in clinically stable patients with COPD. Thorax 52:
981–986, 1997.
3. Baecke JA, Burema J, Frijters JE. A short questionnaire for the
measurement of habitual physical activity in epidemiological studies. Am
J Clin Nutr 36: 936–942, 1982.
4. Bailey SJ, Fulford J, Vanhatalo A, Winyard PG, Blackwell JR,
DiMenna FJ, Wilkerson DP, Benjamin N, Jones AM. Dietary nitrate
supplementation enhances muscle contractile efficiency during knee-ex-
tensor exercise in humans. J Appl Physiol (1985) 109: 135–148, 2010.
5. Bailey SJ, Winyard P, Vanhatalo A, Blackwell JR, Dimenna FJ,
Wilkerson DP, Tarr J, Benjamin N, Jones AM. Dietary nitrate supple-
mentation reduces the O2 cost of low-intensity exercise and enhances
tolerance to high-intensity exercise in humans. J Appl Physiol (1985) 107:
1144–1155, 2009.
6. Barr RG, Mesia-Vela S, Austin JH, Basner RC, Keller BM, Reeves
AP, Shimbo D, Stevenson L. Impaired flow-mediated dilation is associ-
ated with low pulmonary function and emphysema in ex-smokers: the
Emphysema and Cancer Action Project (EMCAP) Study. Am J Respir Crit
Care Med 176: 1200–1207, 2007.
7. Beckman JS, Koppenol WH. Nitric oxide, superoxide, peroxynitrite: the
good, the bad, ugly. Am J Physiol Cell Physiol 271: C1424–C1437, 1996.
8. Berton DC, Barbosa PB, Takara LS, Chiappa GR, Siqueira AC,
Bravo DM, Ferreira LF, Neder JA. Bronchodilators accelerate the
dynamics of muscle O2 delivery and utilisation during exercise in COPD.
Thorax 65: 588–593, 2010.
9. Bickel CS, Gregory CM, Dean JC. Motor unit recruitment during
neuromuscular electrical stimulation: a critical appraisal. Eur J Appl
Physiol 111: 2399–2407, 2011.
10. Borghi-Silva A, Oliveira CC, Carrascosa C, Maia J, Berton DC,
Queiroga F Jr, Ferreira EM, Almeida DR, Nery LE, Neder JA.
Respiratory muscle unloading improves leg muscle oxygenation during
exercise in patients with COPD. Thorax 63: 910–915, 2008.
11. Chiappa GR, Borghi-Silva A, Ferreira LF, Carrascosa C, Oliveira
CC, Maia J, Gimenes AC, Queiroga F Jr, Berton D, Ferreira EM,
Nery LE, Neder JA. Kinetics of muscle deoxygenation are accelerated at
the onset of heavy-intensity exercise in patients with COPD: relationship
to central cardiovascular dynamics. J Appl Physiol (1985) 104: 1341–
1350, 2008.
12. Clarenbach CF, Senn O, Sievi NA, Camen G, van Gestel AJ, Rossi
VA, Puhan MA, Thurnheer R, Russi EW, Kohler M. Determinants of
endothelial function in patients with COPD. Eur Respir J 42: 1194–1204,
2013.
13. Debigare R, Cote CH, Hould FS, LeBlanc P, Maltais F. In vitro and in
vivo contractile properties of the vastus lateralis muscle in males with
COPD. Eur Respir J 21: 273–278, 2003.
14. Debigare R, Maltais F. The major limitation to exercise performance in
COPD is lower limb muscle dysfunction. J Appl Physiol (1985) 105:
751–753, 2008.
15. Degens H, Sanchez Horneros JM, Heijdra YF, Dekhuijzen PN, Hop-
man MT. Skeletal muscle contractility is preserved in COPD patients with
normal fat-free mass. Acta Physiologica Scand 184: 235–242, 2005.
16. Donaldson AV, Maddocks M, Martolini D, Polkey MI, Man WD.
Muscle function in COPD: a complex interplay. Intl J Chronic Obstruct
Pulmon Dis 7: 523–535, 2012.
17. Eickhoff P, Valipour A, Kiss D, Schreder M, Cekici L, Geyer K,
Kohansal R, Burghuber OC. Determinants of systemic vascular function
in patients with stable chronic obstructive pulmonary disease. Am J Respir
Crit Care Med 178: 1211–1218, 2008.
18. Ferrari M, Binzoni T, Quaresima V. Oxidative metabolism in muscle.
Philos Trans R Soc Lond B Biol Sci 352: 677–683, 1997.
19. Ferreira LF, Poole DC, Barstow TJ. Muscle blood flow-O2 uptake
interaction and their relation to on-exercise dynamics of O2 exchange.
Respir Physiol Neurobiol 147: 91–103, 2005.
20. GOLD Executive Committee. Strategy for the Diagnosis, Management,
and Prevention of COPD. Global Initiative for Chronic Obstructive Lung
Disease (GOLD). 2004. Available from: http://www.goldcopd.org/.
21. Gratton E, Fantini S, Franceschini MA, Gratton G, Fabiani M.
Measurements of scattering and absorption changes in muscle and brain.
Philos Trans R Soc Lond B Biol Sci 352: 727–735, 1997.
22. Guzik TJ, Grodzicki T. “Radical” link between chronic obstructive
pulmonary disease and cardiovascular disease? Hypertension 63: 444–
446, 2014.
23. Harper AJ, Ferreira LF, Lutjemeier BJ, Townsend DK, Barstow TJ.
Human femoral artery and estimated muscle capillary blood flow kinetics
following the onset of exercise. Exp Physiol 91: 661–671, 2006.
24. He ZH, Bottinelli R, Pellegrino MA, Ferenczi MA, Reggiani C. ATP
consumption and efficiency of human single muscle fibers with different
myosin isoform composition. Biophys J 79: 945–961, 2000.
25. Hogan MC, Arthur PG, Bebout DE, Hochachka PW, Wagner PD.
Role of O2 in regulating tissue respiration in dog muscle working in situ.
J Appl Physiol (1985) 73: 728–736, 1992.
26. Hueber DM, Franceschini MA, Ma HY, Zhang Q, Ballesteros JR,
Fantini S, Wallace D, Ntziachristos V, Chance B. Non-invasive and
quantitative near-infrared haemoglobin spectrometry in the piglet brain
during hypoxic stress, using a frequency-domain multidistance instrument.
Phys Med Biol 46: 41–62, 2001.
27. Ives SJ, Harris RA, Witman MA, Fjeldstad AS, Garten RS, McDaniel
J, Wray DW, Richardson RS. Vascular dysfunction and chronic obstruc-
R110 SKELETAL MUSCLE DEOXYGENATION IN COPD
AJP-Regul Integr Comp Physiol • doi:10.1152/ajpregu.00404.2014 • www.ajpregu.org
tive pulmonary disease: the role of redox balance. Hypertension 63:
459–467, 2014.
28. Jones AM, Davies RC, Ferreira LF, Barstow TJ, Koga S, Poole DC.
Reply to Quaresima and Ferrari. J Appl Physiol (1985) 107: 2009.
29. Layec G, Haseler LJ, Hoff J, Richardson RS. Evidence that a higher
ATP cost of muscular contraction contributes to the lower mechanical
efficiency associated with COPD: preliminary findings. Am J Physiol
Regul Integr Comp Physiol 300: R1142–R1147, 2011.
30. Layec G, Haseler LJ, Richardson RS. The effect of higher ATP cost of
contraction on the metabolic response to graded exercise in patients with
chronic obstructive pulmonary disease. J Appl Physiol (1985) 112: 1041–
1048, 2012.
31. Levine S, Bashir MH, Clanton TL, Powers SK, Singhal S. COPD elicits
remodeling of the diaphragm and vastus lateralis muscles in humans. J
Appl Physiol (1985) 114: 1235–1245, 2013.
32. Louvaris Z, Zakynthinos S, Aliverti A, Habazettl H, Vasilopoulou M,
Andrianopoulos V, Wagner H, Wagner P, Vogiatzis I. Heliox increases
quadriceps muscle oxygen delivery during exercise in COPD patients with
and without dynamic hyperinflation. J Appl Physiol (1985) 113: 1012–
1023, 2012.
33. Maltais F, Jobin J, Sullivan MJ, Bernard S, Whittom F, Killian KJ,
Desmeules M, Belanger M, LeBlanc P. Metabolic and hemodynamic
responses of lower limb during exercise in patients with COPD. J Appl
Physiol (1985) 84: 1573–1580, 1998.
34. Mattson JP, Sun J, Murray DM, Poole DC. Lipid peroxidation in the
skeletal muscle of hamsters with emphysema. Pathophysiology 8: 215–
221, 2002.
35. McDonough P, Behnke BJ, Padilla DJ, Musch TI, Poole DC. Control
of microvascular oxygen pressures in rat muscles comprised of different
fibre types. J Physiol 563: 903–913, 2005.
36. Neder JA, Sword D, Ward SA, Mackay E, Cochrane LM, Clark CJ.
Home based neuromuscular electrical stimulation as a new rehabilitative
strategy for severely disabled patients with chronic obstructive pulmonary
disease (COPD). Thorax 57: 333–337, 2002.
37. O’Donnell DE, Laveneziana P, Webb K, Neder JA. Chronic obstructive
pulmonary disease: clinical integrative physiology. Clin Chest Med 35:
51–69, 2014.
38. O’Donnell DE, Webb KA. The major limitation to exercise performance
in COPD is dynamic hyperinflation. J Appl Physiol (1985) 105: 753–755,
2008.
39. Ottenheijm CA, Heunks LM, Sieck GC, Zhan WZ, Jansen SM,
Degens H, de Boo T, Dekhuijzen PN. Diaphragm dysfunction in chronic
obstructive pulmonary disease. Am J Respir Crit Care Med 172: 200–205,
2005.
40. Picard M, Hepple RT, Burelle Y. Mitochondrial functional specializa-
tion in glycolytic and oxidative muscle fibers: tailoring the organelle for
optimal function. Am J Physiol Cell Physiol 302: C629–C641, 2012.
41. Porcelli S, Marzorati M, Pugliese L, Adamo S, Gondin J, Bottinelli R,
Grassi B. Lack of functional effects of neuromuscular electrical stimula-
tion on skeletal muscle oxidative metabolism in healthy humans. J Appl
Physiol (1985) 113: 1101–1109, 2012.
42. Puente-Maestu L, Lazaro A, Humanes B. Metabolic derangements in
COPD muscle dysfunction. J Appl Physiol (1985) 114: 1282–1290, 2013.
43. Richardson RS, Leek BT, Gavin TP, Haseler LJ, Mudaliar SR, Henry
R, Mathieu-Costello O, Wagner PD. Reduced mechanical efficiency in
chronic obstructive pulmonary disease but normal peak VO2 with small
muscle mass exercise. Am J Respir Crit Care Med 169: 89–96, 2004.
44. Richardson RS, Sheldon J, Poole DC, Hopkins SR, Ries AL, Wagner
PD. Evidence of skeletal muscle metabolic reserve during whole body
exercise in patients with chronic obstructive pulmonary disease. Am J
Respir Crit Care Med 159: 881–885, 1999.
45. Sala E, Roca J, Marrades RM, Alonso J, Gonzalez De Suso JM,
Moreno A, Barbera JA, Nadal J, de Jover L, Rodriguez-Roisin R,
Wagner PD. Effects of endurance training on skeletal muscle bioener-
getics in chronic obstructive pulmonary disease. Am J Respir Crit Care
Med 159: 1726–1734, 1999.
46. Siqueira AC, Borghi-Silva A, Bravo DM, Ferreira EM, Chiappa GR,
Neder JA. Effects of hyperoxia on the dynamics of skeletal muscle
oxygenation at the onset of heavy-intensity exercise in patients with
COPD. Respir Physiol Neurobiol 172: 8–14, 2010.
47. Stary CM, Hogan MC. Effect of varied extracellular PO2 on muscle
performance in Xenopus single skeletal muscle fibers. J Appl Physiol
(1985) 86: 1812–1816, 1999.
48. Szentesi P, Zaremba R, van Mechelen W, Stienen GJ. ATP utilization
for calcium uptake and force production in different types of human
skeletal muscle fibres. J Physiol 531: 393–403, 2001.
49. van Hees HW, Dekhuijzen PN, Heunks LM. Levosimendan enhances
force generation of diaphragm muscle from patients with chronic obstruc-
tive pulmonary disease. Am J Respir Crit Care Med 179: 41–47, 2009.
50. Verma S, Wang CH, Li SH, Dumont AS, Fedak PW, Badiwala MV,
Dhillon B, Weisel RD, Li RK, Mickle DA, Stewart DJ. A self-fulfilling
prophecy: C-reactive protein attenuates nitric oxide production and inhib-
its angiogenesis. Circulation 106: 913–919, 2002.
51. Vivodtzev I, Lacasse Y, Maltais F. Neuromuscular electrical stimulation
of the lower limbs in patients with chronic obstructive pulmonary disease.
J Cardiopulm Rehabil Prev 28: 79–91, 2008.
52. Wagner PD. Skeletal muscles in chronic obstructive pulmonary disease:
deconditioning, or myopathy? Respirology 11: 681–686, 2006.
53. Wilson DF, Erecinska M, Drown C, Silver IA. Effect of oxygen tension
on cellular energetics. Am J Physiol Cell Physiol 233: C135–C140, 1977.
54. Wust RC, Morse CI, de Haan A, Rittweger J, Jones DA, Degens H.
Skeletal muscle properties and fatigue resistance in relation to smoking
history. Eur J Appl Physiol 104: 103–110, 2008.
R111SKELETAL MUSCLE DEOXYGENATION IN COPD
AJP-Regul Integr Comp Physiol • doi:10.1152/ajpregu.00404.2014 • www.ajpregu.org
